Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-09-20
1992-07-07
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 514 15, 514 16, 424 89, A61K 3912, A61K 3702, C07K 706, C07K 708
Patent
active
051283190
ABSTRACT:
An active peptide consisting essentially of 7 to about 30 residence and having a sequence that corresponds to a conserved domain of an HIV protein is disclosed, as is a multimer containing that peptide, an aqueous composition containing the multimer and methods of using and making the same. The aqueous composition containing an immunologically effective amount of an active peptide multimer, when introduced into an immunocompetent host animal in an immunologically effective amount, is capable of inducing cellular immunity against the native HIV protein to which the active peptide of the multimer corresponds in sequence, but is not capable of inducing production of antibodies that immunoreact with that native HIV protein.
REFERENCES:
patent: 4474795 (1984-10-01), Arnon et al.
patent: 4493795 (1985-01-01), Nextor, Jr. et al.
patent: 4725669 (1988-02-01), Essex et al.
patent: 4818527 (1989-04-01), Thornton et al.
Modrow et al, "Computer-Assisted Analysis of Envelope Protein Sequences of Seven Human Immunodeficiency Virus Isolates", J. of Virology, Feb. 1987, pp. 570-578.
Wain-Hobson et al., "Nucleotide Sequence of the AIDS Virus, LAV", Cell, vol. 40, 9-17, Jan. 1985.
Shinnick et al., "Synthetic Peptide Immmunogens as Vaccines", Ann. Rev. Microbiol. 1983, 37:425-46.
Watari et al, "A Synthetic Peptide Induces Long-Term Protection from Lethal Infection with Herpes Simplex Virus 2", J. Exp. Med. 165:459-470, 1987.
Heber-Katz et al, "Long-Term Protection from a Lethal HSV Challenge in the Absence of a Detectable Antibody Response", Modern Approaches to Vaccines, Cold Spring Harbor Lab. 1985.
Heber-Katz et al, "Peptide-Lipid Conjugates as Anti-Viral T Cell Vaccines. Parameters of Protection", Modern Approaches to Vaccines, Cold Spring Harbor Laboratory, 1985, p. 63.
International Patent Application WO86/06414, published Nov. 6, 1986.
International Patent Application WO85/00807, published Feb. 28, 1985.
C&EN, 65:24 (1987).
Buller, et al., NATURE, 328:77-79 (1987).
Barnes, SCIENCE, 236:1423-1425 (1987); 237:128-130 (1987).
Salk, NATURE, 327:473-476 (1987).
Newmark, NATURE, 325:290, (1987); 327:458 (1987).
Barnes, SCIENCE, 236:255-257 (1987).
Mitsuya and Broder, NATURE, 325:773-778 (1987).
Chanh, et al., EMBO. JOURNAL, 5:3065-3073 (1986).
Gallo, SCIENTIFIC AMERICA, Jan. 1987, pp. 47-56.
Livingstone and Fathman, ANN. REV. IMMUNOL., 5:477-501 (1987).
Milich and McLauchlan, SCIENCE, 234:1563-1566 (1986).
Walker, et al., SCIENCE, 234:1563-1566 (1986).
Bloom, NATURE, 327:193 (1987).
Putney, et al., SCIENCE, 234:1392-1395 (1986).
Reiher, et al., PROC. NATL. ACAD. SCI. USA, 83:9188-9192 (1986).
Lagrain, J. VIROL., 60:1141-1144 (1986).
Earl, et al., SCIENCE, 234:728-731 (1986).
Maddon, et al., CELL, 47:333-348 (1986).
Robey, et al., PROC. NATL. ACAD. SCI. USA, 83:7023-7027 (1986).
Zarling, et al., NATURE, 323:344-346 (1986).
Milich, et al., J. EXP. MED., 164:532-547 (1986).
Kennedy, et al., SCIENCE, 231:1555-1559 (1986).
Berzofsky, SCIENCE, 229:932-940 (1985).
Hopp, MOL. IMMUNOL., 21:13-16 (1984).
Hirsch and Kaplan, SCIENTIFIC AMERICAN, pp. 76-85.
Putney et al., AIDS Vaccine Research and Clinical Trials, Eds. Putney, S. D. & Bolognesi, D. P., Marcel Dekker, Inc., New York and Basel, pp. 3-61.
Cease & Berzofsky, AIDS Vaccine Research and Clinical Trials, Eds. Putney, S. D. & Bolognesi, D. P., Marcel Dekker, Inc., New York and Basel, pp. 139-156.
Emini, AIDS Vaccine Research and Clinical Trials, Eds. Putney, S. D. & Bolognesi, D. P., Marcel Dekker, Inc., New York and Basel, pp. 369-378.
Kast et al., PNAS, 88:2283-2287, 1991.
Sastry & Arlinghaus, Curr. Sci., 5:699-707, 1991.
LaRosa et al., Science, 249:932-935, 1990.
Emini et al., J. Virol., 64(8):3674-3678, 1990.
Scott et al., PNAS, 87:8597-8601, 1990.
Javaherian et al., PNAS, 86:6768-6772, 1989.
Devash et al., PNAS, 87:3445-3449, 1990.
Palker et al., PNAS, 85:1932-1936, 1988.
Takahashi et al., PNAS, 85:3105-3109, 1988.
Takahashi et al., J. Exp. Med., 170:2023-2035, 1989.
Takahashi et al., J. Exp. Med., 171:571-576, 1990.
Berzofsky et al., Nature, 334:706-708, 1988.
Bevan, Nature, News and Views, 342:478-479, 1989.
Deres et al., Nature, 342:561-564, 1989.
Cleric et al., Nature, 339:383-385, 1989.
Howell et al., Science, 246:668-670, 1989.
Arthur et al., J. Virol. 63(12):5046-5053, 1989.
Bio/Technology, In the News, 6:345, 1988.
Barnes, Science, Research News, 242:515, 1988; 241:533-534, 1988.
Takeda et al., Science, 242:580-583, 1988.
Homsy et al., Science, 244:1357-1360, 1989.
Miller, Nature-- News and Views, 332:109-110, 1988.
Patarroyo et al., Nature 332:158-161, 1988.
Maddon et al., PNAS, 84:9155-9159, 1987.
Sternberg et al., FEBS Letts., 218(2):231-237, 1987.
Nara et al., PNAS, 84:3797-3801, 1987.
Cease et al., Proc. Natl. Acad. Sci. USA, 84:4249-4253, Jun. 1987.
Board of Regents , The University of Texas System
Nutter Nathan M.
LandOfFree
Prophylaxis and therapy of acquired immunodeficiency syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prophylaxis and therapy of acquired immunodeficiency syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prophylaxis and therapy of acquired immunodeficiency syndrome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1829837